Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:50 pm Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Perceptive Advisors LLC | 1,845,555 3.000% |
-1,648,052 (-47.17%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 5,614,428 9.200% |
1,056,561 (+23.18%) |
Filing History |
| 2022-02-14 10:24 am Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Macquarie Group Limited | 3,767,892 6.150% |
1,003,970 (+36.32%) |
Filing History |
| 2022-02-14 09:01 am Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 2,450,000 4.000% |
-640,200 (-20.72%) |
Filing History |
| 2022-02-10 5:22 pm Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
JANUS HENDERSON GROUP PLC JHG |
4,016,158 6.600% |
-67,395 (-1.65%) |
Filing History |
| 2022-02-10 11:11 am Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 1,302,492 2.130% |
-1,547,508 (-54.30%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 3,880,873 6.340% |
476,430 (+13.99%) |
Filing History |
| 2022-02-02 7:18 pm Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
4,515,145 7.400% |
-310,029 (-6.43%) |
Filing History |
| 2022-02-01 2:44 pm Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
GOLDMAN SACHS GROUP INC GS |
4,599,279 7.500% |
4,599,279 (New Position) |
Filing History |
| 2021-08-13 4:27 pm Purchase |
2021-08-04 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 3,090,200 5.090% |
3,090,200 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 4,557,867 8.900% |
4,557,867 (New Position) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Perceptive Advisors LLC | 3,493,607 6.800% |
3,493,607 (New Position) |
Filing History |
| 2021-02-16 2:40 pm Sale |
2020-12-31 | 13G | RETROPHIN, INC. RTRX |
Consonance Capital Management LP | 0 0.000% |
-2,314,421 (Position Closed) |
Filing History |
| 2021-02-12 3:48 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
JANUS HENDERSON GROUP PLC JHG |
4,083,553 8.000% |
4,083,553 (New Position) |
Filing History |
| 2021-02-12 08:41 am Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Macquarie Group Limited | 2,763,922 5.410% |
2,763,922 (New Position) |
Filing History |
| 2021-02-11 4:31 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Integrated Core Strategies (US) LLC | 727,176 1.400% |
727,176 (New Position) |
Filing History |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 3,404,443 6.670% |
3,404,443 (New Position) |
Filing History |
| 2021-02-03 8:55 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Manulife Financial Corporation | 2,157,055 11.000% |
2,157,055 (New Position) |
Filing History |
| 2021-02-01 08:17 am Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
4,825,174 9.500% |
4,825,174 (New Position) |
Filing History |
| 2021-01-04 4:05 pm Purchase |
2020-12-24 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 2,850,000 5.580% |
2,850,000 (New Position) |
Filing History |